Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
VANCOUVER, British Columbia, Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cuba Ventures Corp. (TSX-V:CUV) (OTCBB: MPSFF) (FRANKFURT:IJA2) (the “Company”) Travel Division - is pleased to announce that it has...
-
Cresemba von Pfizer in Spanien lanciert und nun in allen Top-5 EU-Märkten kommerziell erhältlich Marktzulassung für Cresemba in der Schweiz erhalten Basel, 2. November 2017 - Basilea...
-
Cresemba launched by Pfizer in Spain and is now commercially available in all Top-5 EU marketsMarketing authorization received for Switzerland Basel, Switzerland, November 2, 2017 - Basilea...
-
TORONTO, ON--(Marketwired - October 31, 2017) - Neo Lithium Corp. ("Neo Lithium" or the "Company") (TSX VENTURE: NLC) (OTCQX: NTTHF) is pleased to confirm that the Company has elected to accelerate...
-
Basel, 31. Oktober 2017 - Basilea Pharmaceutica AG (SIX: BSLN) teilte heute mit, dass Prof. Achim Kaufhold nach sieben Jahren Unternehmenszugehörigkeit in den Ruhestand treten wird. Als Nachfolger...
-
Basel, Switzerland, October 31, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that Prof. Achim Kaufhold will retire after seven years with the company. Basilea named...
-
TORONTO, ON--(Marketwired - October 30, 2017) - Neo Lithium Corp. (TSX VENTURE: NLC) (OTCQX: NTTHF)US$1.13 billion (C$1.45 billion) after-tax NPV at 8% discount rate and IRR of 24.4%PEA based on a...
-
Basel, Switzerland, October 23, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the sales of the antifungal Cresemba® (isavuconazole) in the United States exceeded the threshold...
-
Basel, 23. Oktober 2017 - Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass die Produktverkäufe des Antimykotikums Cresemba® (Isavuconazol) in den USA den für die erste kommerzielle...
-
VANCOUVER, BC, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Cuba Ventures Corp. (TSX-V:CUV) (OTCBB:MPSFF) (the “Company”) is pleased to announce the closing of the 1st tranche of its non-brokered private...